Abstract
AIM—To determine the effect of erythromycin on the establishment of enteral feeding in ventilated infants <31 weeks gestation. METHODS—Erythromycin was randomly allocated as an antimicrobial treatment for the first 7 days of life in 76 infants: 35 received erythromycin and 41 acted as controls. Feed toleration, time taken to establish full enteral feeding, vomiting, prescription of glycerine suppositories and occurrence of necrotising enterocolitis were recorded. RESULTS—There were no significant differences between the groups for any of the outcomes. The infants treated with erythromycin reached full feeding at a median (quartile) age of 8 (5-12) days compared with 9 (6-14) days for controls. CONCLUSIONS—Intravenous erythromycin in antimicrobial doses is unlikely to benefit the introduction of feeding in preterm infants.
Full Text
The Full Text of this article is available as a PDF (86.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berseth C. L. Gestational evolution of small intestine motility in preterm and term infants. J Pediatr. 1989 Oct;115(4):646–651. doi: 10.1016/s0022-3476(89)80302-6. [DOI] [PubMed] [Google Scholar]
- Bisset W. M., Watt J. B., Rivers R. P., Milla P. J. Ontogeny of fasting small intestinal motor activity in the human infant. Gut. 1988 Apr;29(4):483–488. doi: 10.1136/gut.29.4.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cavell B. Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand. 1981 Sep;70(5):639–641. [PubMed] [Google Scholar]
- Ferguson A. E., Tappin D. M., Girdwood R. W., Kennedy R., Cockburn F. Breast feeding in Scotland. BMJ. 1994 Mar 26;308(6932):824–825. doi: 10.1136/bmj.308.6932.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jadcherla S. R., Klee G., Berseth C. L. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res. 1997 Sep;42(3):365–369. doi: 10.1203/00006450-199709000-00018. [DOI] [PubMed] [Google Scholar]
- Kerlin P., Zinsmeister A., Phillips S. Relationship of motility to flow of contents in the human small intestine. Gastroenterology. 1982 Apr;82(4):701–706. [PubMed] [Google Scholar]
- Lyon A. J., McColm J., Middlemist L., Fergusson S., McIntosh N., Ross P. W. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998 Jan;78(1):F10–F14. doi: 10.1136/fn.78.1.f10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ng P. C., Fok T. F., Lee C. H., Wong W., Cheung K. L. Erythromycin treatment for gastrointestinal dysmotility in preterm infants. J Paediatr Child Health. 1997 Apr;33(2):148–150. doi: 10.1111/j.1440-1754.1997.tb01018.x. [DOI] [PubMed] [Google Scholar]
- Otterson M. F., Sarna S. K. Gastrointestinal motor effects of erythromycin. Am J Physiol. 1990 Sep;259(3 Pt 1):G355–G363. doi: 10.1152/ajpgi.1990.259.3.G355. [DOI] [PubMed] [Google Scholar]
- Peeters T., Matthijs G., Depoortere I., Cachet T., Hoogmartens J., Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol. 1989 Sep;257(3 Pt 1):G470–G474. doi: 10.1152/ajpgi.1989.257.3.G470. [DOI] [PubMed] [Google Scholar]
- Simkiss D. E., Adams I. P., Myrdal U., Booth I. W. Erythromycin in neonatal postoperative intestinal dysmotility. Arch Dis Child. 1994 Sep;71(2):F128–F129. doi: 10.1136/fn.71.2.f128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomomasa T., Hyman P. E., Itoh K., Hsu J. Y., Koizumi T., Itoh Z., Kuroume T. Gastroduodenal motility in neonates: response to human milk compared with cow's milk formula. Pediatrics. 1987 Sep;80(3):434–438. [PubMed] [Google Scholar]
- Tomomasa T., Miyazaki M., Koizumi T., Kuroume T. Erythromycin increases gastric antral motility in human premature infants. Biol Neonate. 1993;63(6):349–352. doi: 10.1159/000243954. [DOI] [PubMed] [Google Scholar]